Gokaldas Exports Q1 FY27 results: Revenue Rs 751 Cr, PAT Rs 68 Cr. Key highlights, performance, FY27 outlook. Read full results analysis here.

Mufin Green Finance Q1 FY27 results: Revenue Rs 76 Cr, PAT Rs 14 Cr. Key highlights, performance, FY27 outlook. Read full results analysis here.

AvenuesAI Q1 FY27 results: Revenue Rs 2,680 Cr, PAT Rs 82 Cr. Key highlights, performance, FY27 outlook. Read full results analysis here.

Shilchar Technologies Q1 FY27 results: Revenue Rs 134 Cr, PAT Rs 20 Cr. Key highlights, performance, FY27 outlook. Read full results analysis here.

Esab India Q1 FY27 results: Revenue Rs 421 Cr, PAT Rs 56 Cr. Key highlights, performance, FY27 outlook. Read full results analysis here.

Jubilant Agri and Consumer Products Q1 FY27 results: Revenue Rs 523 Cr, PAT Rs 46 Cr. Key highlights, performance, FY27 outlook. Read full results analysis here.

Five pros including specialty branded portfolio in dental and ophthalmology, and four cons including limited scale and export market challenges, of Indoco Remedies share.

GSP Crop Science Q1 FY27 results: Revenue Rs 385 Cr, PAT Rs 26 Cr. Key highlights, performance, FY27 outlook. Read full results analysis here.

Viyash Scientific Q1 FY27 results: Revenue Rs 946 Cr, PAT Rs 79 Cr. Key highlights, performance, FY27 outlook. Read full results analysis here.

Jash Engineering Q1 FY27 results: Revenue Rs 149 Cr, PAT Rs 5 Cr. Key highlights, performance, FY27 outlook. Read full results analysis here.